| Basics |
| Company: |
Sutro Biopharma, Inc. |
| IPO Date: |
October 12, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$145.95M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.29 | 3.26%
|
| Avg Daily Range (30 D): |
$0.07 | 3.63%
|
| Avg Daily Range (90 D): |
$0.10 | 3.69%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.37M |
| Avg Daily Volume (30 D): |
.85M |
| Avg Daily Volume (90 D): |
.82M |
| Trade Size |
| Avg Trade Size (Sh.): |
103 |
| Avg Trade Size (Sh.) (30 D): |
160 |
| Avg Trade Size (Sh.) (90 D): |
156 |
| Institutional Trades |
| Total Inst.Trades: |
639 |
| Avg Inst. Trade: |
$1.63M |
| Avg Inst. Trade (30 D): |
$1.03M |
| Avg Inst. Trade (90 D): |
$1.57M |
| Avg Inst. Trade Volume: |
.16M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.62M |
| Avg Closing Trade (30 D): |
$1.31M |
| Avg Closing Trade (90 D): |
$1.31M |
| Avg Closing Volume: |
139.74K |
|
|
|
|
| News |
Sep 19, 2024 @ 4:08 PM
Cancer Research Sees Major Boost as New Breakthrou...
Source: Prnewswire
|
Sep 11, 2024 @ 12:00 PM
Sutro Biopharma to Host Research Forum Highlightin...
Source: Sutro Biopharma, Inc.
|
May 13, 2024 @ 9:10 PM
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T...
Source: Zacks Equity Research
|
May 13, 2024 @ 8:30 PM
Sutro Biopharma Reports First Quarter 2024 Financi...
Source: Sutro Biopharma, Inc.
|
May 13, 2024 @ 2:00 PM
Analysts Estimate Sutro Biopharma, Inc. (STRO) to ...
Source: Zacks Equity Research
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.55
|
$-.59
|
$-.59
|
|
Diluted EPS
|
$-1.55
|
$-.59
|
$-.59
|
|
Revenue
|
$ 160.96M
|
$ 8.52M
|
$ 25.71M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -123.95M
|
$ -48.79M
|
$ -48.02M
|
|
Operating Income / Loss
|
$ -130.04M
|
$ -67.92M
|
$ -48.69M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 92.73M
|
$ 83.79M
|
$ 25.57M
|
|
PE Ratio
|
|
|
|
|
